Prestige Consumer Healthcare
PBH
#3877
Rank
NZ$5.57 B
Marketcap
NZ$115.94
Share price
-0.67%
Change (1 day)
-21.63%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): NZ$7.02

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is NZ$6.80. In 2024 the company made an earnings per share (EPS) of NZ$7.20 an increase over its 2023 EPS that were of NZ-$2.70.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$7.02-2.53%
2024NZ$7.20-367.08%
2023NZ-$2.70-138.33%
2022NZ$7.0411.7%
2021NZ$6.3013.6%
2020NZ$5.55-651.67%
2019NZ-$1.01-148.78%
2018NZ$2.06-83.29%
2017NZ$12.33437.23%
2016NZ$2.30-34.13%
2015NZ$3.4852.94%
2014NZ$2.28-8.11%
2013NZ$2.48
2011NZ$1.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.66 174.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
NZ$11.58 70.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.33 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.28-66.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.28-7.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$10.30 51.48%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$0.67-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.31-7.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
NZ-$49.63-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$2.04-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel